Eleven Biotherapeutics Inc (NASDAQ:EBIO)

2.85
Delayed Data
As of May 28
 -0.10 / -3.39%
Today’s Change
2.73
Today|||52-Week Range
14.07
-76.01%
Year-to-Date

Today’s Trading

Previous close2.95
Today’s open2.93
Day’s range2.82 - 2.97
Volume272,714
Average volume (3 months)469,369
Market cap$57.1M
Dividend yield--
Data as of 05/28/2015

Growth & Valuation

Earnings growth (last year)-66.90%
Earnings growth (this year)+40.17%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+68.14%
P/E ratioNM
Price/Sales77.56
Price/Book1.44

Competitors

 Today’s
change
Today’s
% change
PARNParnell Pharmaceutic...+0.25+5.83%
ADMPAdamis Pharmaceutica...-0.09-2.13%
NYMXNymox Pharmaceutical...-0.01-0.95%
MTEXMannatech Inc+0.29+1.38%
Data as of 05/28/2015

Financials

Next reporting dateAugust 12, 2015
EPS forecast (this quarter)-$0.27
Annual revenue (last year)$2.2M
Annual profit (last year)-$34.2M
Net profit margin-1,522.78%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Abbie C. Celniker
Vice President-Finance &
Operations
John J. McCabe
Corporate headquarters
Cambridge, Massachusetts

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers